The global antibody market is projected to experience substantial growth, with an estimated market size of USD 266.83 billion in 2024. Driven by a robust compound annual growth rate (CAGR) of 8.1% from 2024 to 2034, the market is expected to reach a value of USD 581.42 billion by the end of the forecast period, representing an absolute dollar growth of approximately USD 315 billion.
This growth trajectory is fueled by the increasing demand for targeted therapies, which are revolutionizing treatments in oncology, immunology, and other medical fields. As biopharmaceutical companies focus on developing advanced monoclonal and polyclonal antibodies, the antibodies market continues to expand, providing effective solutions for complex diseases and improving patient outcomes.
Innovations in antibody production, along with advancements in genetic engineering and biotechnology, are expected to drive new opportunities within the antibody sector. With an increasing number of antibody-based therapies receiving regulatory approval, the market outlook remains positive as healthcare providers and patients alike seek more precise and personalized treatment options.
Antibody Market Trends & Analysis
- As the prevalence of autoimmune diseases is on the rise, the demand for antibody drugs has strengthened over the last couple of years. Moreover, the rising application of antibodies in chronic disease treatment is anticipated to create more opportunities for antibody market expansion in the near future.
- Novel biosimilar antibody manufacturers are slashing their prices to compete with branded antibody manufacturers, especially in the European market. With the expiration of patents of renowned products, a boost in demand for biosimilar antibodies can be expected in upcoming years.
Competitive Landscape for Antibody Market
Leading market players are working towards developing new antibodies to remain competitive in the present market. They are also researching to create long-acting antibody drugs to reduce healthcare costs and attract chronic patients.
In order to gain a competitive edge in the antibody testing market, key players are developing oral and noninvasive treatments using antibodies to treat chronic ailments. Strategic mergers and acquisitions for portfolio expansion are in the cards as well.
Key Players Profiled in the Antibody Market Report
- Novartis AG
- F. Hoffmann-La Roche AG
- Johnson & Johnson
- Takeda Pharmaceutical Company Limited
- Amgen Inc.
A Full Report Analysis
Key Segments Covered by Antibodies Industry Survey Report
By Disease Indication:
- Cardiovascular Diseases
- CNS Disorders
- Cancer
- Autoimmune Disorders
- Other Disease Indications
By Product Type:
- Monoclonal Antibodies
- Polyclonal Antibodies
- Antibody-drug Complexes
By End User:
- Hospitals
- Long-term Care Facilities
- Research Institutes
- Other End Users
By Region:
- North America
- Latin America
- Europe
- East Asia
- South Asia and Pacific
- Middle East and Africa (MEA)
Author By:
Sabyasachi Ghosh (Associate Vice President at Future Market Insights, Inc.) holds over 12 years of experience in the Healthcare, Medical Devices, and Pharmaceutical industries. His curious and analytical nature helped him shape his career as a researcher.
Identifying key challenges faced by clients and devising robust, hypothesis-based solutions to empower them with strategic decision-making capabilities come naturally to him. His primary expertise lies in areas such as Market Entry and Expansion Strategy, Feasibility Studies, Competitive Intelligence, and Strategic Transformation.
Holding a degree in Microbiology, Sabyasachi has authored numerous publications and has been cited in journals, including The Journal of mHealth, ITN Online, and Spinal Surgery News.
About Future Market Insights (FMI)
Future Market Insights, Inc. (ESOMAR certified, recipient of the Stevie Award, and a member of the Greater New York Chamber of Commerce) offers profound insights into the driving factors that are boosting demand in the market. FMI stands as the leading global provider of market intelligence, advisory services, consulting, and events for the Packaging, Food and Beverage, Consumer Technology, Healthcare, Industrial, and Chemicals markets. With a vast team of over 400 analysts worldwide, FMI provides global, regional, and local expertise on diverse domains and industry trends across more than 110 countries.
Contact Us:
Future Market Insights Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-347-918-3531
For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedIn| Twitter| Blogs | YouTube